News
Print PDF

Practice Areas

IPR Enforcement: Recombinant Products, Electronic Devices

Friday, March 09, 2018
Sandler, Travis & Rosenberg Trade Report

Recombinant Products. The ITC has terminated, without the imposition of import restrictions, patent infringement investigation 337-TA-1066 of certain recombinant factor IX products. This action is based on the withdrawal of the complaint by complainants Bioverativ Inc., Bioverativ Therapeutics Inc., and Bioverativ U.S. LLC.

Electronic Devices. The ITC has terminated, without the imposition of import restrictions, patent infringement investigation 337-TA-1072 of certain Wi-Fi enabled electronic devices and components thereof. This action is based on the withdrawal of the allegations in the complaint by complainants Sharp Corporation and Sharp Electronics Corporation.

To get news like this in your inbox daily, subscribe to the Sandler, Travis & Rosenberg Trade Report.

Customs & International Headlines